Open Access Green as soon as Postprint is submitted to ZB.
		
    A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure.
        
        Hum. Genet. 134, 627-636 (2015)
    
    
    
	    Proprotein convertase subtilisin/kexin (PCSK) enzymes cleave and convert their immature substrates into biologically active forms. Polymorphisms in the PCSK genes have been reported to associate with human diseases and phenotypes, including hypercholesterolemia and blood pressure (BP), and targeting PCSKs is considered a promising future form of drug therapy. PCSK processing is readily induced upon upregulation of the enzyme, but the genetic factors contributing to PCSK expression have not been thoroughly characterized. To gain a comprehensive understanding of the genetic regulation of PCSK expression, we performed, for the first time, a genome-wide expression quantitative trait loci (eQTL) analysis using mRNA expression in >1400 human peripheral blood samples from the Cardiovascular Risk in Young Finns Study and ca. ten million single-nucleotide polymorphisms (SNPs). The expression data showed clear expression for FURIN, PCSK5, PCSK7 and MBTPS1 (membrane-bound transcription factor peptidase, site 1) mRNAs in virtually all tested samples. A discovery analysis demonstrated a genome-wide significant (p < 5 × 10−8) association with the selected PCSK probes for 1024 variants, which were located at ten independent loci. Of these loci, 5/10 could be confirmed to regulate PCSK expression in two additional and independent sample sets. Finally, a phenotypic analysis demonstrated that a novel cis-eQTL SNP rs4702 for FURIN is strongly associated with both diastolic (p = 0.012) and systolic (p = 0.035) BP levels, as well as peripheral vascular resistance (p = 0.003). These findings indicate that the expression of the PCSK enzymes is regulated by genetic factors, which have biological roles in health and disease.
	
	
      Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Times Cited
Scopus
Cited By
		Cited By
Altmetric
		
	    4.824
		1.224
		23
		24
		
	    Annotations
	    
		
		     
		    
		
	    
	
		
	
	    Special Publikation
	    
		
		     
		
	    
	
	
	
	    Hide on homepage
	    
		
		     
		
	    
	
	
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
     
    
    
        Keywords
        Human Atherosclerotic Plaques; Impedance Cardiography; Natriuretic Peptide; Cardiovascular Risk; Young Finns; Disease; Association; Cells; Eqtls; Hypertension
    
 
     
    
    
        Language
        english
    
 
    
        Publication Year
        2015
    
 
     
    
        HGF-reported in Year
        2015
    
 
    
    
        ISSN (print) / ISBN
        0340-6717
    
 
    
        e-ISSN
        1432-1203
    
 
    
     
     
	     
	 
	 
    
        Journal
        Human Genetics
    
 
	
    
        Quellenangaben
        
	    Volume: 134,  
	    Issue: 6,  
	    Pages: 627-636 
	    
	    
	
    
 
    
         
        
            Publisher
            Springer
        
 
        
            Publishing Place
            New York
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Institute of Epidemiology (EPI)
    
 
    
        POF-Topic(s)
        30202 - Environmental Health
    
 
    
        Research field(s)
        Genetics and Epidemiology
    
 
    
        PSP Element(s)
        G-504091-001
    
 
     
     	
    
        PubMed ID
        25813623
    
    
    
        WOS ID
        WOS:000354196200009
    
    
        Scopus ID
        84925625658
    
    
        Erfassungsdatum
        2015-04-03